Nigella Sativa Seed Oil is a phytopharmaceutical preparation derived from plant source material through extraction or expression processes that concentrate pharmacologically active secondary metabolites. The chemical fingerprint of Nigella Sativa Seed Oil varies with botanical species, chemotype, geographic origin, and harvest season, necessitating validated HPLC-based analytical methods capable of identity confirmation and quantification of characteristic marker compounds. PDE derivation for botanical preparations must address the complexity of multiple co-occurring active and potentially toxic constituents, often drawing on the toxicological profile of key individual chemical entities as surrogates for the whole extract.
Study duration uncertainty factor F3 in PDE derivation for Nigella Sativa Seed Oil compensates for the data gap between the duration of available toxicology studies and the chronic lifetime pharmaceutical exposure scenario.
